Lipid-Based Solutions To Increase Bioavailability Presented At Drug Delivery And Formulation Summit




Somerset, N.J. – February 5, 2015 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Dr. Vincent Plassat, Scientific Affairs Manager, will present a workshop at the upcoming Drug Delivery and Formulation Summit, to be held at the Swissôtel, Düsseldorf, Germany, on the 9th – 11th February, 2015.

Dr. Plassat’s session, on February 10th at 10.25 a.m., is entitled “Accelerating the development of compounds with bioavailability limitations” and will discuss the development of orally-delivered, lipid-based systems that can be used to improve the bioavailability of New Chemical Entities that offer therapeutic promise for patients, but exhibit limiting physico-chemical attributes for conventional, solid oral dose delivery.

Dr. Plassat joined Catalent in 2013, initially as a formulation scientist, drawing upon his experience in lipid-based softgel development for the oral delivery of macromolecules, before becoming Scientific Affairs Manager. Prior to joining Catalent, he worked at OTR3, a Paris-based startup company, developing targeted therapies.

Dr. Plassat is a pharmacist, and received a Ph.D. from the University of Paris Sud in Pharmaceutical Technologies.